How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
作者信息
Mascolini M, Wensing A M, Boucher C A
出版信息
IAPAC Mon. 2001 Mar;7(3):85-90.
PMID:11697306
Abstract
摘要
相似文献
1
How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
IAPAC Mon. 2001 Mar;7(3):85-90.
2
[Incorporation of the test of resistance to antiretroviral drugs in clinical practice].
Med Clin (Barc). 1999 Mar 27;112(11):412-5.
3
HIV drug resistance testing: an update for the clinician.
AIDS Clin Care. 2001 Oct;13(10):89-91, 94-6, 100.
4
Putting resistance to the test.
Posit Living. 2001 Apr;10(3):15-6, 43-6.
5
HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
Antivir Ther. 2007;12(6):957-62.
6
Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
Antivir Ther. 2003 Oct;8(5):443-54.
7
New insights into HIV resistance testing: nursing guidelines and implications.
J Assoc Nurses AIDS Care. 2007 May-Jun;18(3):74-86. doi: 10.1016/j.jana.2007.03.003.
8
[GESIDA Consensus document on the use of resistance studies in clinical practice].
Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):53-60.
9
Resistance testing grows more prevalent in U.S.
AIDS Alert. 1998 Sep;13(9):103-4.
10
HIV drug resistance testing: data be damned.
Res Initiat Treat Action. 2000 Dec;6(4):25-7.
Zotero 插件